BioMarin Pharmaceutical Inc. (BMRN) PT Lowered to $80 at Oppenheimer
October 24, 2019 7:02 AM
Oppenheimer analyst Leland Gershell lowered the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $80.00 (from $81.00) while maintaining ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
